HQL

abrdn Life Sciences Investors
HQL

Overview Fund Trends Analyst Outlook Journalist POV

49 hedge funds and large institutions have $57.5M invested in abrdn Life Sciences Investors in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less funds holding

Funds holding: →

22% less capital invested

Capital invested by funds: $73.9M → $57.5M (-$16.4M)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

Holders
49
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.51M
2
+$1.33M
3
+$689K
4
DA
Doliver Advisors
Texas
+$590K
5
GC
Guggenheim Capital
Illinois
+$587K

Top Sellers

1
-$8.25M
2
-$4.36M
3
-$3.27M
4
WAM
Weiss Asset Management
Massachusetts
-$2.25M
5
CS
Credit Suisse
Switzerland
-$1.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$237K
27
$206K
28
$203K
29
$201K
30
$188K
31
$163K
32
$144K
33
$57K
34
$43K
35
$32K
36
$31K
37
$29K
38
$29K
39
$24K
40
$21K
41
$21K
42
$18K
43
$17K
44
$4K
45
$1K
46
$1K
47
–
48
–
49
–
50
–
1
2
3